MHRA and NICE launch aligned pathway for faster medicines regulation. The simplified framework is part of the UK Government's plans to ensure the life sciences sector reaches its full potential. The move is intended to speed up the drug approval process. Alignment of the MHRA and NICE will make regulation more efficient. The framework is designed to support innovative therapies. The goal is to speed up patients' access to new medicines. The initiative is part of a broader strategy for the development of the biotechnology sector.